Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Edwin DeJesus, MD

Medical Director
Orlando Immunology Center, University of Central Florida College of Medicine

Poster(s):

(1596) Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV: Week 104 Results

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET
(1603) Efficacy, safety and tolerability of switching to dolutegravir/lamivudine in virologically suppressed adults living with HIV on bictegravir/emtricitabine/tenofovir alafenamide -the DYAD study

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET